Related Experiment Videos
[Depression in children and adolescents].
Gil Zalsman1, Boris Birmaher, David A Brent
1Neuroscience Division, Columbia University, USA. zalsman@neuron.cpmc.columbia.edu
Harefuah
|April 29, 2006
Summary
Early onset depression is a common, recurring childhood disorder that can persist into adulthood. Research is ongoing to understand its causes and improve treatments, especially for children.
Area of Science:
- Child and Adolescent Psychiatry
- Developmental Psychology
- Genetics
Context:
- Early onset depression is a prevalent, recurrent, and familial disorder with lifelong implications.
- It frequently co-occurs with substance abuse, bipolar disorder, suicidal behavior, and impaired psychosocial development.
- Genetic, psychological, and environmental factors, along with gene-environment interactions, contribute to its etiology.
Purpose:
- To review the current understanding of early onset depression, including its risk factors and therapeutic interventions.
- To highlight recent FDA warnings regarding pharmacological treatments in pediatric populations.
- To emphasize the need for further research into the efficacy, safety, and etiological factors of early onset depression.
Summary:
- Early onset depression is a significant childhood disorder with familial patterns and potential for adult persistence.
- Comorbidities include substance abuse, bipolar disorder, suicidal behavior, and psychosocial impairment.
- Risk factors encompass genetic, psychological, and environmental influences, with gene-environment interactions playing a role.
- Evidence-based therapies include cognitive, interpersonal, and pharmacological approaches.
- Recent FDA warnings necessitate careful consideration of pharmacotherapy in pediatric patients.
- Further research is crucial for assessing intervention efficacy and safety and elucidating etiological factors.
Impact:
- Informs clinicians and researchers about the complexities of early onset depression.
- Guides the development of safer and more effective treatment strategies for children and adolescents.
- Highlights critical areas for future research in pediatric mental health.
- Raises awareness of the FDA's concerns regarding psychotropic medication use in youth.